[Phosphate binding therapy].
Kinugasa
Eriko
E
Department of Internal Medicine, Showa University Northern Yokohama Hospital.
Ito
Hidetoshi
H
D000327:Adsorption; D000818:Animals; D017322:Clinical Trials, Phase II as Topic; D004852:Epoxy Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000517:prevention & control; D007676:Kidney Failure, Chronic / Q000150:complications; D009999:Ossification, Heterotopic / Q000209:etiology / Q000517:prevention & control; D010710:Phosphates / Q000097:blood; D011073:Polyamines; D011095:Polyethylenes / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry; D006435:Renal Dialysis / Q000009:adverse effects; D000069603:Sevelamer
D004852:Epoxy Compounds; D010710:Phosphates; D011073:Polyamines; D011095:Polyethylenes; D000069603:Sevelamer